Abstract:
An active antenna, a base station, a method for refreshing the amplitude and phase, and a signal processing method are disclosed to simplify the structure of a phase shifter and guarantee the reliability of the phase shifter. The active antenna or the base station includes an antenna dipole array, a transceiver array, a digital processing unit (DPU), and a transceiving calibration unit. During signal reception, the transceiver demodulates a radio frequency (RF) signal of the antenna dipole into an IQ analog signal, and outputs the IQ analog signal to the DPU; the DPU converts the demodulated IQ analog signal into an IQ digital signal, and performs digital beam forming (DBF) on the IQ digital signal according to the transceiving calibration unit; during signal transmission, the transceiver modulates the IQ analog signal of the DPU into an RF signal, and outputs the RF signal to the antenna dipole; the DPU converts a signal of a base band unit (BBU) into an IQ digital signal in serial/parallel (S/P) mode, and performs DBF on the IQ digital signal according to the transceiving calibration unit.
Abstract:
Provided herein are steroidal compounds that are androsta-5,7-dienes or pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof and cholecalciferol derivatives hydroxylated at one or more of C1, C17, C20, C23, C24, C25, and C26 which includes pharmaceutical, cosmeceutical or nutraceutical compositions of the steroidal compounds as shown in Tables 1A, 2A and 3. Also provided is a method for producing hydroxylated metabolites of cholecalciferol via CYP11A1, CYP24, CYP27A1, or CYP27B1 enzyme systems where the hydroxylase has an activity to hydroxylate position C1 or C20 or other position of the sidechain of a secosteroid or its 5,7-dieneal precursor and the hydroxylated metabolites so produced. Methods are provided for inhibiting proliferation of either a normally or abnormally proliferating cell, for modifying immune activity, or for treating a condition associated with the proliferating or quiescent cell or immune cells by contacting the cell with or administering any of the compounds described herein.
Abstract:
The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.
Abstract:
An active antenna, a base station, a method for refreshing the amplitude and phase, and a signal processing method are disclosed to simplify the structure of a phase shifter and guarantee the reliability of the phase shifter. The active antenna or the base station includes an antenna dipole array, a transceiver array, a digital processing unit (DPU), and a transceiving calibration unit. During signal reception, the transceiver demodulates a radio frequency (RF) signal of the antenna dipole into an IQ analog signal, and outputs the IQ analog signal to the DPU; the DPU converts the demodulated IQ analog signal into an IQ digital signal, and performs digital beam forming (DBF) on the IQ digital signal according to the transceiving calibration unit; during signal transmission, the transceiver modulates the IQ analog signal of the DPU into an RF signal, and outputs the RF signal to the antenna dipole; the DPU converts a signal of a base band unit (BBU) into an IQ digital signal in serial/parallel (S/P) mode, and performs DBF on the IQ digital signal according to the transceiving calibration unit.
Abstract:
Provided herein are steroidal compounds that are androsta-5,7-dienes or a pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof which includes pharmaceutical compositions of the steroidal compounds as shown in Tables 1 and 2. Also provided is a method for producing hydroxylated metabolites of cholecalciferol or ergocalciferol via the P450scc (CYP11A1) or CYP27B1 enzyme systems where the hydroxylase has an activity to hydroxylate position C20 of a secosteroid or its 5,7-dieneal precursor and the hydroxylated metabolites so produced. In addition, a method for inhibiting proliferation of either a normally or abnormally proliferating cell by contacting the cell with any of the compounds described herein. A related method is provided of treating a condition associated with the proliferating cell such as a cancer, a skin disorder, a defect in cell differentiation, cosmetic, prophylaxsis, or healthy cell maintenance.
Abstract:
FIG. 1 is top, rear and left-side perspective view of an electric motorcycle for kids embodying my new design; FIG. 2 is bottom, front and left-side perspective view thereof; FIG. 3 is a left-side elevation view thereof; FIG. 4 is a right-side elevation view thereof; FIG. 5 is a front elevation view thereof; FIG. 6 is a rear elevation view thereof; FIG. 7 is a top plan view thereof; FIG. 8 is a bottom plan view thereof; and, FIG. 9 is an enlarged and partial perspective view of area 9 in FIG. 1. The dot-dash broken lines do not form part of the claimed design and are provided for annotative purposes to show the area being enlarged.
Abstract:
Provided herein are steroidal compounds that are androsta-5,7-dienes or a pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof which includes pharmaceutical compositions of the steroidal compounds as shown in Tables 1 and 2. Also provided is a method for producing hydroxylated metabolites of cholecalciferol or ergocalciferol via the P450scc (CYP11A1) or CYP27B1 enzyme systems where the hydroxylase has an activity to hydroxylate position C20 of a secosteroid or its 5,7-dieneal precursor and the hydroxylated metabolites so produced. In addition, a method for inhibiting proliferation of either a normally or abnormally proliferating cell by contacting the cell with any of the compounds described herein. A related method is provided of treating a condition associated with the proliferating cell such as a cancer, a skin disorder, a defect in cell differentiation, cosmetic, prophylaxsis, or healthy cell maintenance.
Abstract:
Methods and apparatus are provided for receiving AISG protocol signals sent by one or more local devices and adding corresponding labels to the AISG protocol signals, where the labels are used to identify mapping relationships between the local devices that send the AISG protocol signals and peer devices. The AISG protocol signals to which the labels have been added are packed into data packet and sent to a peer combiner through a shared feeder. The peer combiner unpacks the data packet and sends the AISG protocol signals to corresponding peer devices according to the labels added to the AISG protocol signals.
Abstract:
Method, system, and programs for balancing work load in a distributed system. A plurality of multi-dimensional load metrics are received from a plurality of resource units in the distributed system. Based on the received plurality of multi-dimensional load metrics and a global statistical load model, a load deviance for each resource unit is computed. The plurality of resource units in the distributed system are then ranked based on the load deviance of each resource unit. At least one load balancing action is further determined based on the ranked resource units and at least one load balancing policy.